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Integrative Physiology
Hyperphosphorylation of the Cardiac Ryanodine Receptor
at Serine 2808 Is Not Involved in Cardiac Dysfunction After
Myocardial Infarction
Hongyu Zhang,* Catherine A. Makarewich,* Hajime Kubo,* Wei Wang, Jason M. Duran, Ying Li,
Remus M. Berretta, Walter J. Koch, Xiongwen Chen, Erhe Gao, Héctor H. Valdivia, Steven R. Houser
Rationale: Abnormal behavior of the cardiac ryanodine receptor (RyR2) has been linked to cardiac arrhythmias
and heart failure (HF) after myocardial infarction (MI). It has been proposed that protein kinase A (PKA)
hyperphosphorylation of the RyR2 at a single residue, Ser-2808, is a critical mediator of RyR dysfunction,
depressed cardiac performance, and HF after MI.
Objective: We used a mouse model (RyRS2808A) in which PKA hyperphosphorylation of the RyR2 at Ser-2808 is
prevented to determine whether loss of PKA phosphorylation at this site averts post MI cardiac pump dysfunction.
Methods and Results: MI was induced in wild-type (WT) and S2808A mice. Myocyte and cardiac function were
compared in WT and S2808A animals before and after MI. The effects of the PKA activator Isoproterenol (Iso)
on L-type Ca2 current (ICaL), contractions, and [Ca2]I transients were also measured. Both WT and S2808A
mice had depressed pump function after MI, and there were no differences between groups. MI size was also
identical in both groups. L type Ca2 current, contractions, Ca2 transients, and SR Ca2 load were also not
significantly different in WT versus S2808A myocytes either before or after MI. Iso effects on Ca2 current,
contraction, Ca2 transients, and SR Ca2 load were identical in WT and S2808A myocytes before and after MI
at both low and high concentrations.
Conclusions: These results strongly support the idea that PKA phosphorylation of RyR-S2808 is irrelevant to the
development of cardiac dysfunction after MI, at least in the mice used in this study. (Circ Res. 2012;110:831-840.)
Key Words: myocardial infarction  ryanodine receptor  heart failure  PKA hyperphosphorylation
Myocardial infarction (MI)1 is a major cause of leftventricular dysfunction that leads to heart failure (HF)
and arrhythmogenic sudden cardiac death.2 The development
of HF after MI involves remodeling at the molecular, cellular,
and organ levels and is characterized by ventricular dilatation,
elevated systolic wall stress, and poor cardiac pump function.
Dysregulated intracellular Ca2 handling plays a major role
in the pathophysiology of contractile, electrophysiological,
and structural abnormalities that evolve after MI.3 There are
alterations in the abundance and phosphorylation state of
almost all Ca2 regulatory proteins in the failing heart.4–5
Collectively, these changes produce alterations in diastolic
and systolic Ca2 and diminished responses to sympathetic
regulatory stimulation.6–7 There is some evidence, primarily
from the Marks laboratory,8,9 that hyperphosphorylation of
the Ca2 release channel (Ryanodine receptor; RyR2) plays a
significant independent role in the altered Ca2 regulation of
the heart after MI. This idea was tested in the current study.
Editorial, see p 796
In This Issue, see p 795
Cardiac myocyte contraction occurs when the action po-
tential activates voltage-gated L-type Ca2 channels
(LTCCs)10 in the cell membrane and its invaginations, the
T-tubules. A small amount of Ca2 influx through these
LTCCs triggers the release of much larger amount of Ca2
from the sarcoplasmic reticulum (SR) through activation of
RyR2. This process is termed Ca2-induced Ca2 release,
and RyR2s are essential for this process.
LTCCs in T-tubules are in close proximity to the junctional
SR that contains RyRs, and together they form a “couplon,”11
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where Ca2-induced Ca2 release takes place. SR Ca2
release within a couplon is regenerative and occurs when 1 or
more LTCCs open, to raise local junctional cleft [Ca2], to
promote binding to RyRs, to cause their opening. The
resultant flux of SR Ca2 into the junctional space further
elevates cleft Ca2 and this activates other nearby RyRs to
induce locally regenerative Ca2 release.12 In normal hearts,
all couplons within a cell appear to be activated with each
heart beat,11 and it is the sum of the Ca2 release from all
couplons that produces the systolic Ca2 transient that
activates the contractile apparatus.13 Relaxation occurs
through Ca2 reuptake into the SR through the SR Ca2
ATPase (SERCa) and Ca2 extrusion through the Na/Ca
exchanger.14,15
Length-independent changes in the force of cardiac con-
traction (contractility) are critical to normal cardiac function
and are largely brought about by altering the amplitude and
duration of the systolic [Ca2] transient. Contractility is
efficiently regulated in the normal heart and this primarily
results from activation of adrenergic signaling pathways
through protein kinase A (PKA). Ca2 regulatory PKA
targets include the LTCC (to increase Ca2 current and SR
Ca2 load), phospholamban (to increase the activity of
SERCa, promote more rapid removal of Ca2 from the
cytoplasm and to help increase SR Ca2 loading),16 and RyR
(to increase Ca2 dependent opening).16,17 The roles of
PKA-mediated LTCC and SERCa regulation in the normal
control of cardiac contractility are widely accepted.18,19 How-
ever, the independent role of PKA-mediated regulation of
RyR2 activity as a major regulator of cardiac contractile
strength is not broadly supported in the literature.20 This
effect is predicted from the fact that increasing the Ca2-
dependent opening probability of RyR2 should not increase
the number of couplons that release stored Ca2, since all
couplons participate in normal EC coupling.21–23
In cardiac disease, the contractile demands on the heart are
persistently increased, and chronic activity of the sympathetic
nervous system is needed to maintain cardiac output.24 This
heightened hyperadrenergic state of the stressed heart is
thought to contribute to depression of contractility reserve
and cardiac arrhythmias.25 Many studies have shown that
deranged Ca2 handling in heart failure involves altered
SERCa activity and reduced LTCC abundance with increased
activity.6,26–27 The Marks laboratory has proposed that abnor-
mal PKA-mediated phosphorylation of RyR2 (at Serine
2808) is centrally involved in defective Ca2 handling in
HF.9,28 PKA-mediated hyperphosphorylation of RyR at
S2808 is proposed to increase RyR Ca2-dependent opening
(leak), leading to depletion of SR Ca2 stores.9 Studies by the
Marks group have shown that PKA-mediated hyperphosphor-
ylation of RyR2 at serine-2808 is a critical mediator of
normal cardiac contractility regulation29,30 and cardiac dys-
function after MI.8 These ideas were explored in experiments
with genetically modified mice in which Ser-2808 is mutated
to alanine (S2808A), to eliminate PKA-mediated phosphor-
ylation.29 In previous studies, we31 and others32 were unable
to show any alterations in sympathetic regulation of cardiac
or myocyte function in RyR S2808A mice. Given the critical
nature of this topic, we studied if prevention of RyR2
phosphorylation after MI preserved cardiac function and
reduced premature death, consistent with the development of
cardiac dysfunction after MI being dependent on PKA phos-
phorylation of a single amino acid on RyR2.
In the present study, we examined if the absence of PKA
phosphorylation of RyR at Ser-2808 (RyRS2808A mice)
reduced the damaging effects of MI on cardiac structure and
function. Cardiac performance was compared before and after
MI in wild-type (WT) and RyRS2808A mice. Isoproterenol
(Iso) effects on L-type Ca2 current (ICaL), contractions and
[Ca2]I transients were also measured. Our results showed
that both WT and S2808A mice have depressed pump
function after MI, but we could not show a difference
between groups. MI size was identical in both groups. L-type
Ca2 current, contractions, and [Ca2]I transients were also
not significantly different in WT versus S2808A mice myo-
cytes either before or after MI. Iso effects on Ca2 current,
contraction, and Ca2 transients were identical in WT and
S2808A myocytes before and after MI at both low and high
concentrations. These results strongly support the idea that
PKA phosphorylation of RyR-S2808 plays little or no role in
the development of cardiac dysfunction after MI in these
mice.
Methods
All methods have been described in detail in previous reports and are
described in detail in the Online Supplement. Briefly, myocardial
infarction was induced in WT and S2808A mice by permanent
occlusion of the left anterior descending coronary artery.33 Cardiac
function was measured with echocardiography. At the time of death,
hearts were removed and used for functional studies (isovolumic
hearts and isolated myocytes), tissue was used for Western or
biochemical analyses, or hearts were fixed and processed for
histological studies.
Results
Cardiac Function In Vivo After MI
MI was induced by permanent ligation of the left anterior
descending coronary artery. Before MI, there was no signif-
icant difference in cardiac function or structure between WT
and RyR-S2808A mice. Ejection fraction (EF), fractional
shortening (FS), left ventricle internal diameter, and septum
wall thickness were not different in WT and RyR-S2808A
mice (Figure 1). These data are consistent with those we have
Non-standard Abbreviations and Acronyms
EF ejection fraction
FS fractional shortening
HF heart failure
ICaL L-type Ca
2 current
Iso isoproterenol
LTCC L-type Ca2 channel
MI myocardial infarction
RyR ryanodine receptor
SR sarcoplasmic reticulum
WT wild-type
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previously reported.31 One week after MI, both groups of
mice had significant decreases of EF (pre-MI versus 1 week
post-MI; WT: 58.142.81 versus 32.873.88; S2808A:
61.593.57 versus 26.903.36) and fractional shortening
(pre-MI versus 1 week post-MI; WT: 29.082.72 versus
15.682.05; S2808A: 32.922.73 versus 12.131.90) (Fig-
ure 1A and 1B), but there was no significant difference
between WT and S2808A mice. Four weeks after MI, EF and
FS were still depressed and there were no differences between
WT and S2808A hearts (WT versus S2808A; EF:
25.651.90 versus 27.144.07; FS: 12.822.08 versus
11.940.93). There were significant changes in ventricular
geometry and wall thickness after acute MI. The LV was
dilated in all hearts and chamber size was significantly
increased in the first week and 4 weeks after MI (Figure 1C).
Septum wall thickness was decreased significantly in the first
week after MI in both groups and became stable at the end of
4 weeks (Figure 1D). There were no significant differences in
geometry or wall thickness between WT and S2808A mice
after MI.
Survival and Cardiac Phenotype After MI
Animals were studied for 4 weeks after MI surgery. There
was no significant difference in survival between WT and
S2808A mice (87% of all animals survived the 4-week study
interval). Heart weight was significantly greater in MI mice
compared with sham mice (Figure 2A), but there was no
difference between control and S2808A hearts. Lung weight
was also significantly increased after MI in S2808A mice,
suggesting more severe heart failure. Liver weight was
slightly increased in S2808A mice, but there was no signifi-
cant difference between the groups 4 weeks after MI (Figure
2B and 2C). These data show that after MI, both WT and
S2808A mice had cardiac dysfunction with signs of acute HF.
We were unable to show any significant benefit in survival,
structure, or function in S2808A versus WT mice.
Infarct Length and Fibrosis Were Not Different in
WT and S2808A Mice
Infarct length was measured 4 weeks after MI. There was no
significant difference in infarct length between WT and
S2808A mice (WT versus S2808A: 32.552.38% versus
26.553.03%) (Figure 2D). Representative examples of in-
farcted cardiac tissue and fixed heart tissue sections are
shown in Online Figure I, A through C. We also measured
fibrosis in noninfarcted (remote) zones of infarcted hearts.
The collagen content in the remote zone was not significantly
different in WT and S2808A infarcted hearts (Figure 2E).
These data show that WT and S2808A mice had similar
infarct size and fibrotic remodeling after MI.
Western Blot Analysis
If PKA-mediated RyR-S2808 phosphorylation plays a critical
role in either the normal physiology of the mouse heart or in
the progression of cardiac dysfunction after MI, then elimi-
nating this site would be expected to induce adaptive altera-
tions in other Ca2 regulatory proteins, as shown in other
studies.34 Ca2 regulatory proteins including the L-type Ca2
channel 1C subunit, phospholamban, total and phosphory-
lated at Thr-17 (PLBt, PT17), RyR2 total protein (RyRt), and
RyR2 phosphorylated at S2808 (RyRp) were measured with
Western analysis in sham and MI mice (representative blots
are shown in Online Figure II). Average data are shown in
Figure 3. There was no significant difference in the abun-
dance of any of these Ca2 regulatory proteins between WT
and S2808A mice either in sham or MI groups (Figure 3).
There was a significant increase of PLB phosphorylation at
Threonine17 in both WT and S2808A hearts after MI, but
there were no differences between the groups. An antibody
against phosphorylated RyR-Ser2808 did not react to RyR-
S2808A samples. RyR Ser2808 phosphorylation was signif-
icant in sham hearts and increased after MI (Online Figure II
and Figure III). These results show that there are no signifi-
cant differences in Ca2 regulatory protein abundance or
phosphorylation either before or after MI in WT versus
S2808A hearts. These results are inconsistent with a signifi-
cant role for Ser2808 phosphorylation in the normal physiol-
ogy of the mouse heart or in the deranged structure and
function after MI.
Figure 1. Cardiac structure and function are not
different in WT and S2808A animals before or
after MI. Ejection fraction (A), fractional shortening
(B), LV internal diameter (C), and septum wall
thickness (D) were measured with echocardiogra-
phy before and 1 and 4 weeks after MI. *P0.05,
**P0.01 between pre-MI and post-MI within
groups.
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LTCC Current (ICa,L) in S2808A Mice After MI
Elimination of a critical element in normal EC coupling or in
the regulation of the contractile response to stress would be
expected to have a major effect on baseline cardiac function.
If not, as we have shown in this and other studies,31 then
significant adaptation of related molecules would be needed
to offset the defective or lost protein. An example would be
the conditional NCX knockout mouse34 that survives with
Figure 2. MI causes cardiac remodeling and
fibrosis in WT and S2808A hearts. A through C,
Heart weight (HW), lung weight (LW), and liver
weight (LiverW) normalized to body weight (BW)
(HW/BW, LW/BW, LiverW/BW) in sham- and
MI-operated mice after 1 and 4 weeks surgery. D,
Infarct length 4 weeks after MI. E, Fibrotic area
(blue) in remote zones of trichrome-stained cardiac
histological sections was measured 4 weeks after
MI. $P0.05 between WT and S2808A mice.
**P0.01 between sham and MI.
Figure 3. Western analysis of Ca2 regulatory
proteins in WT and S2808A mice 4 weeks after
MI. A through E, Total RyR (RyRt), S2808 phos-
phorylated RyR (RyRp), LTCC alpha1C, SERCa2,
and phosphorylated Phospholamban (PT17) are
shown. The phosphorylated forms of RyR2 and
PT17 increased in MI hearts. *P0.05, **P0.01
versus sham.
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adaptive reduction in the L-type Ca2 current density. If
phosphorylation of RyR at Ser-2808 is critical to the regula-
tion of EC coupling in health and disease, then its loss should
either induce a significant basal phenotype (which it did not)
or there should be adaptive changes in other EC coupling
proteins. The major protein that would be expected to change
would be the L-type Ca2 channel, with a known essential
role in EC coupling. Therefore, we measured ICa-L density
and responsiveness to catecholamines. Peak ICa,L density was
not significantly different in WT and S2808A myocytes after
sham operations (WT sham: 10.711.78 pA/pF, n6;
S2808A sham: 11.352.18 pA/pF, n5). Isoproterenol
(Iso) increased ICa,L similarly in both WT and S2808A
myocytes (sham WT after Iso: 16.550.58 pA/pF n5; sham
S2808A after Iso: 17.953.82 pA/pF, n5) (Figure 4A
through 4C). Iso also caused similar hyperpolarizing shifts (a
signature of PKA phosphorylation effect) in the voltage
dependence of ICa,L activation in sham control and S2808A
myocytes (Online Figure III, A). After MI, there was also no
difference in peak ICa,L in WT and S2808A myocytes (WT
MI: 11.762.1pA/pF, n7; S2808A MI: 9.000.98
pA/pF, n7). Iso increased ICa,L significantly in both WT
(16.22.7 pA/pF, n7) and S2808A (15.23.0 pA/pF,
n7) myocytes, but again no significant difference was
detected between groups (Figure 4A, 4B, and 4D). The
voltage dependence of activation of ICa,L in S2808A myo-
cytes was not significantly different than control myocytes
either before or after Iso treatment (Online Figure III, B).
Collectively, these data show that there are no significant
changes in LTCC density or PKA regulation in RyR-S2808A
mice either before or after MI.
Contractions and [Ca2]i Transients in WT and
S2808A Mice Before and After MI
Twitch contractions and [Ca2]i transients were studied at 0.5
and 2 Hz in the absence and presence of Iso (representative
data are shown in Online Figure IV and V). Low and high
concentrations of Iso were tested because others have sug-
gested that differences in catecholamine responsiveness of
WT and S2808A myocytes are only observed at low concen-
trations.29 The rationale for this is unclear since the hyper-
phosphorylation hypothesis predicts that differences between
WT and S2808A animals should be most robust when WT
RyR is hyperphosphorylated. Nevertheless, we compared the
effects of lower [Iso] on WT and RyR-S2808A animals and
myocytes.
There were no significant differences in the amplitude of
contraction (FS) or the [Ca2]i transients between WT or
S2808A myocytes (0.5 and 2 Hz) either before or after MI.
Low and high [Iso] caused identical changes in contraction
and [Ca2]i transients in both groups under all conditions
tested (Figures 5 and 6). Low [Iso] (10 nmol/L) caused robust
increases in contraction and [Ca2]i transients in all myo-
cytes, and there were no differences between WT and
S2808A myocytes at any tested pacing rate or with or without
MI. High [Iso] did not increase the amplitude of contraction
or the [Ca2]i transient beyond that produced by 10 nmol/L
Iso in either group under any conditions tested. These results
Figure 4. L-type Ca2 current (ICa,L) in
sham and post-MI myocytes. A, Repre-
sentative ICa,L in sham or post-MI myo-
cytes from WT and S2808A hearts. B,
Representative ICa,L after 1 mol/L isopro-
terenol in sham or post-MI myocytes from
WT and S2808A hearts. C and D,
Current-voltage relationships in sham and
MI myocytes Iso. E and F, Peak ICa,L
and voltage dependence of ICa,L activa-
tion in sham or post-MI myocytes Iso
from WT and S2808A hearts. #P0.05
between Iso.
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do not support the hypothesis that the loss of PKA-mediated
phosphorylation of RyR2 at S2808 has any effect on baseline
cardiac myocyte function in the absence or presence of low or
high [Iso].
MI induced changes (half-width and tau) in the duration of
contractions and [Ca2]i transients (Figures 5 and 6 and
Online Figures IV and V). These changes were identical in
WT and S2808A mice. Slowing and prolongation of contrac-
tion after MI probably results from changes in a host of
processes, but changes in phosphorylation of RyR2 at
S2808A do not appear to be a central element of this
functional remodeling.
Low and high [Iso] was also tested in vivo (Online Figure
VI), and we could not define a difference in effects in WT and
S2808A animals. These results are similar to those we have
shown previously in isolated hearts from these animals.31
Collectively, these results suggest that PKA-mediated phos-
phorylation of RyR-S2808 is not critical modulator of myo-
cyte function in health or disease, at least under our
conditions.
SR Ca2 Load in WT and S2808A Myocytes
SR Ca2 load is often decreased in myocytes isolated from
failing hearts,35 and this is thought to be, at least in part, due
to an abnormal “leak” of Ca2 from the SR. PKA-mediated
hyperphosphorylation of RyR at S2808 has been proposed as
the mechanism that leads to SR “leak” and a reduction in
SR Ca2 stores in hyperadrenergic states,36 but other
studies suggest that CaMKII mediated RyR phosphoryla-
tion at an alternative site is the cause of this “leak.”37 In the
present experiments, SR Ca2 load was measured as the
caffeine releasable SR Ca2 transient (Figure 7). The
effects of Iso on SR Ca2 load were determined in sham
and MI myocytes Iso.
There were no significant differences in SR Ca2 load or
the decay rate of these transients (not shown) between WT
and S2808A myocytes under control conditions (Figure 7C).
Iso caused a significant increase in SR Ca2 load in both WT
and S2808A myocytes (Figure 7C), and the extent or rate of
decay (not shown) was not different.
MI caused a significant reduction in SR Ca2 load in both
WT and S2808A myocytes, and there were no differences
between groups (Figure 7C). Iso had very small effects on SR
Ca2 load in MI myocytes, and again there were no differ-
ences between groups (Figure 7C). These results do not
support the hypothesis that hyperphosphorylation of RyR at
S2808 is critical to the SR Ca2 leak that develops after MI.
Figure 5. Low and high [Iso] had identical effects on contractions of WT and S2808A myocytes from sham and MI hearts. A and
B, Myocyte contractions Iso in sham and post-MI myocytes. C and D, Average half-width (ms) of fractional shortening Iso in WT
and S2808A myocytes from sham or post-MI hearts. E and F, Average time to 50% relaxation (ms) of fractional shortening Iso in WT
and S2808A myocytes from sham or post-MI hearts. *P0.05 sham versus MI, #P0.05 between Iso; 10 and 100 nmol/L Iso were
used in this study.
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Discussion
The present study evaluated the hypothesis that PKA-
mediated phosphorylation of RyR-S2808 is critical for the
normal regulation of cardiac contractility and that RyR
hyperphosphorylation is critical for the cardiac dysfunction
that develops after MI. Although the RyR hyperphosphory-
lation hypothesis has been supported by some previous
studies,8 the topic is still controversial,38,39 and many critical
issues have not been resolved.
In the normal heart, contractility is primarily regulated by
the sympathetic nervous system. To increase myocyte con-
tractility, sympathetic signaling cascades activate PKA. The
PKA target proteins that become phosphorylated include the
LTCC, PLB, RyR, and troponin C. Increased myocyte con-
tractility involves an increased amplitude and reduced dura-
tion of the systolic [Ca2] transient. The contribution of
increased Ca2 influx through the phosphorylated LTCC
complex and increased Ca2 uptake by the SR after PLB
phosphorylation are well described in many laboratories.40
The idea that PKA-mediated phosphorylation of RyR plays a
critical role in the regulation of cardiac contractility is less
well accepted and is not supported by modeling studies.41
Studies with a S2808A mouse from the Marks group support
a significant role for RyR2 phosphorylation at S2808 in the
normal regulation of cardiac contractility29,30 and in the
response of the heart to pathological stress.8 The present
results with a similar mouse are inconsistent with these
previous reports.
MI reduces functional cardiac mass, and a hyperadrenergic
state is required to maintain cardiac pump function. The
persistent hyperadrenergic state eventually contributes to
abnormal myocyte function42 and death43 that precipitates
heart failure. The question posed here was if preventing
phosphorylation of RyR2 at a single amino acid is sufficient
to reduce adverse functional and structural remodeling after
MI. Our results suggest that eliminating PKA-mediated
phosphorylation at RyRS2808 has no impact on remodeling
after MI, at odds with results of studies discussed below.
A number of reports8,17,30,44strongly support the hypothesis
that PKA-mediated phosphorylation of RyR at S2808 causes
the RyR-associated protein FKBP12.6 (also called Calstabin)
to dissociate from RyR and that this increases the Ca2
dependent opening of RyR. Hyperphosphorylation of RyR2
by PKA has been proposed as the cause of RyR “leak” that
leads to reduced SR content and contractility in HF.8 How-
ever, there is equally compelling data suggesting that PKA-
Figure 6. Low and high [Iso] had identical effects on Ca2 transients of WT and S2808A myocytes from sham and MI hearts. A
and B, Myocyte peak Ca2 transients Iso in sham and post-MI myocytes. C and D, Half-width of Ca2 transients Iso in myocytes
from sham or post-MI hearts. E and F, Average tau of Ca2 transients Iso in myocytes from sham or post-MI hearts. *P0.05
between sham and MI, #P0.05 between Iso.
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mediated phosphorylation of RyR at S2808 has little or no
role in the regulation of myocyte function in the normal or
diseased heart.31–32,38 There are studies showing that there are
no appreciable differences in the level of phosphorylation of
RyR2 and basal channel activity between failing and nonfail-
ing canine hearts.38 S2808A animals with pressure overload
did not have better function than WT animals.32 In addition,
we have previously suggested that phosphorylation of RyR2
at Ser-2808 is not involved in the adrenergic regulation of
normal cardiac contractility.31 These data are consistent with
a detailed modeling study from the Bers group23 that predicts
that increasing RyR Ca2-mediated opening should have very
little effect on contractility. In addition, others have shown
that CaMKII-mediated phosphorylation of RyR at S2814
rather than PKA-mediated phosphorylation of S2808 is re-
sponsible for regulation of RyR function45 and that PKA
phosphorylation of RyR does not induce significant displace-
ment of FKBP from RyR2.46 The results we report in the
present investigation are consistent with those that have been
unable to document any significant role for RyRS2808
phosphorylation in health and disease.
We were unable to find any significant difference in any
Ca2 regulatory process in S2808A mice. Our logic for
looking at other molecules involved in EC coupling and the
regulation of cardiac contractility in S2808A mice was that
because everyone agrees that S2808A mice have no basal
phenotype, either S2808 phosphorylation is unimportant or
there are adaptive changes in other proteins involved in the
regulation of myocyte Ca. An example of this in mouse
models is the conditional cardiac Na/Ca2 exchanger (NCX)
KO that was expected to die after eliminating the major Ca2
efflux mechanism in the normal heart, but did not die.34 It was
shown that these mice were able to live with a large reduction
in Ca2 efflux by an adaptive reduction in Ca2 influx
through the L-type Ca2 channel.34 If RyR-S2808 phosphor-
ylation is a critical component of the physiological regulation
of cardiac contractile function, then related adaptations would
be expected because there is no basal phenotype. We were
unable to detect any change in abundance, phosphorylation,
or function of any Ca2 regulatory protein involved in Ca2
entry or efflux and SR Ca2 uptake, storage, and release.
We were unable to detect any beneficial effect of loss of
RyRS2808 phosphorylation after MI. Importantly we were
able to show reduced SR Ca2 loading in MI myocytes, but
there were similar reductions in WT and S2808A myocytes.
These results support the idea that alterations in SR Ca2
uptake, storage, and release are involved in post MI func-
tional remodeling but do not support a role for hyperphos-
phorylation of RyR S2808 in these changes.
It is difficult to find common ground with those studies that
have reported such strong evidence for the RyRS2808 hyper-
phosphorylation hypothesis.8 A recent report29 suggested that
the reason for the differences between those studies finding
and not finding different catecholamine effects in WT versus
Figure 7. Sarcoplasmic retic-
ulum Ca2 content is identi-
cal in WT and S2808A myo-
cytes from sham and MI
hearts. Caffeine-induced SR
Ca2 release was measured in
WT and S2808A myocytes
Iso (10 nmol/L) from sham or
MI mice. A and B, Examples of
Ca2 transients elicited by 0.5
Hz of electric field stimulation
(first 4 traces) followed by
Ca2 transients induced by
caffeine (fifth large trace; peak
indicates SR Ca2 content). C,
Average amplitudes of
caffeine-induced Ca2 tran-
sients Iso in WT and S2808A
myocytes. *P0.05 between
sham and MI, #P0.05
between Iso.
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S2808A mice is related to the fact that studies not detecting
differences used Iso concentrations that were too high.
Interestingly, there were already data in the literature using
low [Iso] that did not support this notion. A previous study31
showed that exposing WT and RyR2808A isovolumic hearts
to 10 nmol/L Iso caused identical increases in contractility in
both groups, whereas when a 10-fold higher concentration
(100 nmol/L) of Iso was used in the recent studies from the
Marks laboratory, reduced Iso effects were seen in S2808A
hearts. Because of this concentration issue, we tested the
effects of lower [Iso] on isolated myocyte function and could
not find any difference in effects in WT and S2808A cells.
Therefore, our present and previous results do not support the
idea that low doses of catecholamines are required to dem-
onstrate differences in cardiac function related to RyR-S2808
phosphorylation. We are at a loss to find an explanation for
the differences between our data and those studies docu-
menting a critical role for this single amino acid in the
regulation of cardiac function in health and disease. One
potential explanation for the differences in the literature
could be that the 2 sets of S2808A mice have a different
genetic background.
In summary, our results do not support a major role of
S2808 PKA phosphorylation on myocyte contractility regu-
lation in health and disease.
Sources of Funding
This study was supported by grants NIH HL089312, HL033921,
HL091799 (to S.R.H.), and HL55438 (to H.H.V.).
Disclosures
None.
References
1. Abbate A, Bussani R, Amin MS, Vetrovec GW, Baldi A. Acute myo-
cardial infarction and heart failure: role of apoptosis. Int J Biochem Cell
Biol. 2006;38:1834–1840.
2. Vetter R, Rehfeld U, Reissfelder C, Weiss W, Wagner KD, Gunther J,
Hammes A, Tschope C, Dillmann W, Paul M. Transgenic overexpression
of the sarcoplasmic reticulum ca2atpase improves reticular Ca2
handling in normal and diabetic rat hearts. FASEB J. 2002;16:1657–1659.
3. Gomez AM, Guatimosim S, Dilly KW, Vassort G, Lederer WJ. Heart
failure after myocardial infarction: altered excitation-contraction
coupling. Circulation. 2001;104:688–693.
4. Kubo H, Margulies KB, Piacentino V III, Gaughan JP, Houser SR.
Patients with end-stage congestive heart failure treated with beta-
adrenergic receptor antagonists have improved ventricular myocyte
calcium regulatory protein abundance. Circulation. 2001;104:1012–1018.
5. Yano M, Ikeda Y, Matsuzaki M. Altered intracellular Ca2 handling in
heart failure. J Clin Invest. 2005;115:556–564.
6. Houser SR, Piacentino V III, Mattiello J, Weisser J, Gaughan JP.
Functional properties of failing human ventricular myocytes. Trends
Cardiovasc Med. 2000;10:101–107.
7. Houser SR, Piacentino V III, Weisser J. Abnormalities of calcium cycling
in the hypertrophied and failing heart. J Mol Cell Cardiol. 2000;32:
1595–1607.
8. Wehrens XH, Lehnart SE, Reiken S, Vest JA, Wronska A, Marks AR.
Ryanodine receptor/calcium release channel PKA phosphorylation: a
critical mediator of heart failure progression. Proc Natl Acad Sci U S A.
2006;103:511–518.
9. Marks AR. Ryanodine receptors/calcium release channels in heart failure
and sudden cardiac death. J Mol Cell Cardiol. 2001;33:615–624.
10. Tsien RW, Bean BP, Hess P, Lansman JB, Nilius B, Nowycky MC.
Mechanisms of calcium channel modulation by beta-adrenergic agents
and dihydropyridine calcium agonists. J Mol Cell Cardiol. 1986;18:
691–710.
11. Inoue M, Bridge JH. Ca2 sparks in rabbit ventricular myocytes evoked
by action potentials: involvement of clusters of l-type Ca2 channels.
Circ Res. 2003;92:532–538.
12. Taur Y, Frishman WH. The cardiac ryanodine receptor (Ryr2) and its role
in heart disease. Cardiol Rev. 2005;13:142–146.
13. Zhang R, Zhao J, Mandveno A, Potter JD. Cardiac troponin I phosphor-
ylation increases the rate of cardiac muscle relaxation. Circ Res. 1995;
76:1028–1035.
14. Barry WH, Bridge JH. Intracellular calcium homeostasis in cardiac
myocytes. Circulation. 1993;87:1806–1815.
15. Kohomoto O, Levi AJ, Bridge JH. Relation between reverse sodium-
calcium exchange and sarcoplasmic reticulum calcium release in guinea
pig ventricular cells. Circ Res. 1994;74:550–554.
16. Xiao B, Tian X, Xie W, Jones PP, Cai S, Wang X, Jiang D, Kong H,
Zhang L, Chen K, Walsh MP, Cheng H, Chen SR. Functional conse-
quence of protein kinase a-dependent phosphorylation of the cardiac
ryanodine receptor: sensitization of store overload-induced ca2 release.
J Biol Chem. 2007;282:30256–30264.
17. Marx SO, Reiken S, Hisamatsu Y, Jayaraman T, Burkhoff D, Rosemblit
N, Marks AR. PKA phosphorylation dissociates fkbp12.6 from the
calcium release channel (ryanodine receptor): defective regulation in
failing hearts. Cell. 2000;101:365–376.
18. Marks AR. Intracellular calcium-release channels: regulators of cell life
and death. Am J Physiol. 1997;272:H597–H605.
19. Marks AR. Cardiac intracellular calcium release channels: role in heart
failure. Circ Res. 2000;87:8–11.
20. Eschenhagen T. Is ryanodine receptor phosphorylation key to the fight or
flight response and heart failure? J Clin Invest. 2010;120:4197–4203.
21. Ginsburg KS, Bers DM. Modulation of excitation-contraction coupling
by isoproterenol in cardiomyocytes with controlled SR Ca2 load and
Ca2 current trigger. J Physiol. 2004;556:463–480.
22. Eisner DA, Trafford AW. No role for the ryanodine receptor in regulating
cardiac contraction? News Physiol Sci. 2000;15:275–279.
23. Shannon TR, Wang F, Bers DM. Regulation of cardiac sarcoplasmic
reticulum ca release by luminal [Ca] and altered gating assessed with a
mathematical model. Biophys J. 2005;89:4096–4110.
24. Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G,
Butler J. The sympathetic nervous system in heart failure physiology,
pathophysiology, and clinical implications. J Am Coll Cardiol. 2009;54:
1747–1762.
25. Mann DL, Bristow MR. Mechanisms and models in heart failure: the
biomechanical model and beyond. Circulation. 2005;111:2837–2849.
26. Hu ST, Liu GS, Shen YF, Wang YL, Tang Y, Yang YJ. Defective Ca(2)
handling proteins regulation during heart failure. Physiol Res. 2011;60:
27–37.
27. Chen X, Piacentino V, III, Furukawa S, Goldman B, Margulies KB,
Houser SR. L-type Ca2 channel density and regulation are altered in
failing human ventricular myocytes and recover after support with
mechanical assist devices. Circ Res. 2002;91:517–524.
28. Marks AR, Priori S, Memmi M, Kontula K, Laitinen PJ. Involvement of
the cardiac ryanodine receptor/calcium release channel in catechol-
aminergic polymorphic ventricular tachycardia. J Cell Physiol. 2002;
190:1–6.
29. Shan J, Kushnir A, Betzenhauser MJ, Reiken S, Li J, Lehnart SE,
Lindegger N, Mongillo M, Mohler PJ, Marks AR. Phosphorylation of the
ryanodine receptor mediates the cardiac fight or flight response in mice.
J Clin Invest. 2010;120:4388–4398.
30. Shan J, Betzenhauser MJ, Kushnir A, Reiken S, Meli AC, Wronska A,
Dura M, Chen BX, Marks AR. Role of chronic ryanodine receptor
phosphorylation in heart failure and beta-adrenergic receptor blockade in
mice. J Clin Invest. 2010;120:4375–4387.
31. MacDonnell SM, Garcia-Rivas G, Scherman JA, Kubo H, Chen X,
Valdivia H, Houser SR. Adrenergic regulation of cardiac contractility
does not involve phosphorylation of the cardiac ryanodine receptor at
serine 2808. Circ Res. 2008;102:e65–e72.
32. Benkusky NA, Weber CS, Scherman JA, Farrell EF, Hacker TA, John
MC, Powers PA, Valdivia HH. Intact beta-adrenergic response and
unmodified progression toward heart failure in mice with genetic ablation
of a major protein kinase a phosphorylation site in the cardiac ryanodine
receptor. Circ Res. 2007;101:819–829.
33. Gao E, Lei YH, Shang X, Huang ZM, Zuo L, Boucher M, Fan Q,
Chuprun JK, Ma XL, Koch WJ. A novel and efficient model of coronary
artery ligation and myocardial infarction in the mouse. Circ Res. 2010;
107:1445–1453.
Zhang et al RyRS2808 Is Irrelevant to Heart Failure 839
 at Thomas Jefferson Universi on August 17, 2013http://circres.ahajournals.org/Downloaded from 
34. Henderson SA, Goldhaber JI, So JM, Han T, Motter C, Ngo A, Chan-
tawansri C, Ritter MR, Friedlander M, Nicoll DA, Frank JS, Jordan MC,
Roos KP, Ross RS, Philipson KD. Functional adult myocardium in the
absence of Na-Ca2 exchange: cardiac-specific knockout of NCX1.
Circ Res. 2004;95:604–611.
35. Piacentino V III, Weber CR, Chen X, Weisser-Thomas J, Margulies KB,
Bers DM, Houser SR. Cellular basis of abnormal calcium transients of
failing human ventricular myocytes. Circ Res. 2003;92:651–658.
36. Marks AR, Reiken S, Marx SO. Progression of heart failure: is protein
kinase a hyperphosphorylation of the ryanodine receptor a contributing
factor? Circulation. 2002;105:272–275.
37. Curran J, Hinton MJ, Rios E, Bers DM, Shannon TR. Beta-adrenergic
enhancement of sarcoplasmic reticulum calcium leak in cardiac myocytes
is mediated by calcium/calmodulin-dependent protein kinase. Circ Res.
2007;100:391–398.
38. Jiang MT, Lokuta AJ, Farrell EF, Wolff MR, Haworth RA, Valdivia HH.
Abnormal Ca2 release, but normal ryanodine receptors, in canine and
human heart failure. Circ Res. 2002;91:1015–1022.
39. Li Y, Kranias EG, Mignery GA, Bers DM. Protein kinase a phosphory-
lation of the ryanodine receptor does not affect calcium sparks in mouse
ventricular myocytes. Circ Res. 2002;90:309–316.
40. Balaguru D, Haddock PS, Puglisi JL, Bers DM, Coetzee WA, Artman M.
Role of the sarcoplasmic reticulum in contraction and relaxation of
immature rabbit ventricular myocytes. J Mol Cell Cardiol. 1997;29:
2747–2757.
41. Puglisi JL, Wang F, Bers DM. Modeling the isolated cardiac myocyte.
Prog Biophys Mol Biol. 2004;85:163–178.
42. Kaye DM, Lefkovits J, Jennings GL, Bergin P, Broughton A, Esler MD.
Adverse consequences of high sympathetic nervous activity in the failing
human heart. J Am Coll Cardiol. 1995;26:1257–1263.
43. Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis
SM, Hendrix GH, Bommer WJ, Elkayam U, Kukin ML, et al. Effect of
oral milrinone on mortality in severe chronic heart failure: the promise
study research group. N Engl J Med. 1991;325:1468–1475.
44. Wehrens XH, Lehnart SE, Huang F, et al. Fkbp12.6 deficiency and
defective calcium release channel (ryanodine receptor) function linked to
exercise-induced sudden cardiac death. Cell. 2003;113:829–840.
45. Huke S, Bers DM. Ryanodine receptor phosphorylation at serine 2030,
2808 and 2814 in rat cardiomyocytes. Biochem Biophys Res Commun.
2008;376:80–85.
46. Guo T, Cornea RL, Huke S, Camors E, Yang Y, Picht E, Fruen BR, Bers
DM. Kinetics of fkbp12.6 binding to ryanodine receptors in permeabilized
cardiac myocytes and effects on ca sparks. Circ Res. 2010;106:1743–1752.
Novelty and Significance
What Is Known?
● After myocardial infarction (MI), sympathetic regulatory pathways are
activated (with heightened activity of protein kinase A [PKA]) to
increase the contractility of surviving myocytes and thereby
maintain cardiac pump performance.
● Some studies propose that PKA-mediated hyperphosphorylation of
a single serine (S2808) on the ryanodine receptor (RyR;
responsible for Ca2 release from the sarcoplasmic reticulum
[SR] is a critical determinant of myocyte contractile and
electric dysfunction after MI.
● Other studies have suggested that phosphorylation of RyRS2808 is
not an essential regulator of RyR function in health and disease.
What New Information Does This Article Contribute?
● Preventing phosphorylation of RyR at S2808 (with an alanine
substitution; RyRS2808A) does not induce a significant change in
cardiac function or in the contractile response to adrenergic
agonists, at either low or high concentrations.
● MI induced similar reductions in cardiac function and myocyte
adrenergic responsiveness in wild-type and RyRS2808A mice.
● Changes in Ca2 regulatory processes after MI, including a reduction
in SR Ca2 stores, were similar in wild type and RyRS2808A mice,
documenting the lack of functional benefit of preventing PKA
phosphorylation of S2808 after MI.
MI causes regional cellular death in the heart and results in
depressed cardiac pump function. Heightened adrenergic sig-
naling with activation of PKA helps maintain cardiac function
after MI but eventually causes myocyte dysfunction. Some
investigators have suggested that PKA-mediated phosphoryla-
tion of RyR at S2808 is critical to the normal regulation of
cardiac contractile function and that hyperphosphorylation of
S2808 is responsible for SR disturbances that reduce contrac-
tility and promote arrhythmias in disease, making hyperphos-
phorylation of S2808 a therapeutic target. The results of our
study show that RyRS2808 phosphorylation increases after MI
and that SR Ca2 stores are reduced, consistent with SR Ca2
“leak” hypothesis. However, preventing RyRS2808 phosphory-
lation had no effect on adrenergic regulation of myocyte or heart
function in the normal heart, and it did not prevent depressed
function after MI or reductions in SR Ca2 loading after MI. Our
results show that, at least under the experimental conditions
used, PKA-mediated phosphorylation of RyR at S2808 is not a
critical regulator of cardiac contractile function in the normal
heart and that it might not be the mechanism that reduces SR
Ca2 loading and myocyte contractility reserve after MI.
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Detailed Methods 
 
Mice and Experimental Protocol   WT and RyR-S2808A mice were used in these 
studies. The methods used to generate the RyR-S2808A mouse have been described 
previously1. Experiments were performed based on the National Institutes of Health 
Guide for the Care and Use of Laboratory Animals, and all procedures were approved by 
the Temple University Committee on Animal Care. Myocardial infarction (MI) surgeries 
were carried out in mice at the age of 4 months. Mice were anesthetized with 2% 
isoflurane inhalation. A skin incision was made over the left thorax, and the pectoral 
muscles were retracted to expose the ribs. At the level of the fifth intercostal space, the 
heart was exposed and pumped out through an expanded space between ribs. A 
permanent knot or slipknot (for reperfusion purpose) was made around the left anterior 
descending coronary artery (LAD) 2–3 mm from its origin with a 6-0 silk suture. The 
heart was immediately placed back into the intrathoracic space after the knot was tied,, 
followed by manual evacuation of pneumothoraces and closure of muscle and the skin 
suture by means of the previously placed purse-string suture. Sham-operated animals 
were subjected to the same surgical procedures except that the suture was passed 
under the LAD but was not tied 2-3.  
 
Determination of Left Ventricle Infarct Size After MI   After mouse was anesthetized; 
heart was quickly removed and frozen in a dish placed on dry ice for a few minutes. 
Then the heart was quickly sliced into eight 1.2-mm-thick sections perpendicular to the 
long axis of the heart. The sections were incubated in PBS containing 2% 
triphenyltetrazolium chloride (TTC; Sigma) at room temperature for 15 min and digitally 
photographed. TTC-negative staining area (infarcted myocardium) and total 
circumference of section were measured by NIH Image J software. Myocardial infarction 
size (expressed as percentage) was calculated using infarct length divided by total 
circumference of tissue sections. 
 
In-vivo Functional Analysis (Echocardiography, ECHO)   ECHO was performed with 
VisualSonics Velvo 770 machine which is specifically designed for mice and rats. Mice 
were anesthetized with 2% isoflurane initially and then 1% during the ECHO procedure. 
Hearts were viewed in the short-axis between the two papillary muscles and analyzed in 
M-mode. Parameters were to be measured offline (Velvo software) including end-
diastolic diameter (EDD), end-systolic diameter (ESD), posterior wall thickness (PWT), 
and septal wall thickness (SWT) to determine cardiac morphological changes and 
ejection fraction (EF), heart rate and fractional shortening (FS). 
 
Histology Animals were anesthetized by sodium pentobarbital (0.1ml/100g) and 
heparinized intravenously. Hearts were excised, trimmed off excess tissue, weighed, 
washed and then perfused with 10% buffered formalin. The fixed heart tissues were 
dehydrated, embedded in paraffin, sectioned at 5-μm thickness, and then perform 
Masson’s Trichrome staning, which was used to evaluate gross morphology, fiber 
integrity or fibrosis. Images were acquired using SPOTINSIGHT software (Diagnostic 
Instruments Ins.). 3 fields were captured from each tissue section per heart and blue 
area were automatically analyzed using Metamorph 6.1 software (Universal Image 
Corp.). Average blue area percentage was calculated across at least 3 independent 
hearts. 
 
Cellular Functional Analysis  Myocytes were isolated from sham and post-MI animals’ 
hearts at the end of 2-3 weeks to measure cellular fractional shortenting (FS), calcium 
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transients ([Ca2+]i)and L-type calcium current (ICaL). All experiments were done a 35-37oC, 
in superfused myocyte chambers mounted on fluorescence equipped microscopes. All 
myocytes were characterized with the same series of experiments. The detailed 
medthods are described as below. 
 
Myocyte Isolation 
Mice were anesthetized with sodium pentobarbital (0.1ml/100g). The heart was excised, 
weighed and cannulated on a constant-flow langendorff apparatus. The heart was 
digested by retrograde perfusion of normal tyrode solution containing 180 U/mL 
collagenase and (mM): CaCl2 0.02, glucose 10, HEPES 5, KCl 5.4, MgCl2 1.2, NaCl 
150, sodium pyruvate 2, pH 7.4. When the tissue has softened, left ventricular tissue is 
gently minced, filtered, and equilibrated in Tyrodes solution with 0.2 mM CaCl2, and 1% 
bovine serum alumin( BSA) at room temperature. Routinely, our initial yield is >90% rod-
shaped VMs, and >80% calcium-tolerant, rod-shaped VMS survive by the end of the 
isolation.  
  
ICaL Measurement  ICaL was measured in a sodium-free and potassium-free solution. 
Isolated myocytes were placed in a chamber mounted on an inverted microscope (Nikon 
Diaphot) and perfused with 1mM calcium-containing Tyrode solution. Both the inflow 
solution and the chamber were water-heated to maintain the temperature at 36±1°C. A 
4-5 MΩ pipette filled with a Cs+-containing solution [composition in mM: 130 Cs-
aspartate, 10 N-methyl-Dglucamine (NMDG), 20 tetraethylammonium chloride, 10 
HEPES, 2.5 Tris-ATP, 1 MgCl2, and 10 EGTA, pH 7.2] was used to obtain gigaseals. 
Once a gigaseal was formed, the patch was ruptured and the cell was dialyzed for 10 
min. The extracellular bath was then changed to a 2mM calcium -containing Cs+ 
substitution bath solution (composition in mM: 2 4-aminopyridine, 2 CaCl2, 5.4 CsCl, 10 
glucose, 5 HEPES, 1.2 MgCl2, and 150 NMDG, pH 7.4 with CsOH). Membrane voltage 
was controlled by an Axopatch 2A voltage-clamp amplifier and digitized by Digidata 
1322 using pClamp8 software (Molecular Devices). Once the signal was converted to 
digital format, it was stored on a personal computer for off-line analysis with Clampfit 10 
(Axon Instruments). The flow of the bathing solution was 2–3 ml/min 4. 
 
Fractional Shortening Magnitude, Ca2+ Transients and SR Load Measurements 
Fractional Shortening Magnitude and transients were measured simultaneously in 
myocytes incubated with Tyrodes solution containing 1mM Ca2+ at rates of 0.5 and 2 Hz 
stimulation with an edge detector. [Ca2+]i were measured in paced myocytes loaded with 
Fluo-4AM as described in previous studies 5. Once a steady state had been reached, 10 
and 100nM Isoproterenol (Iso) was applied through the perfusion solution. Once a stable 
effect of Iso had been achieved, at least 20 continuous contractions and Ca2+ transients 
were recorded and averaged for analysis. Ca2+ transients were fit with a single-
exponential decay function to determine the decay rate. To measure SR Ca2+ content, 
myocytes were paced at 0.5 Hz for 10 consecutive contractions, and 10 mM caffeine 
was then rapidly applied via a glass pipette close to the myocyte with a Pico spritzer 6-7. 
Since caffeine cannot be repetitively applied on the same cell, the SR Ca2+ content after 
10nM Iso was measured by a caffeine spritz after stable effects of Iso on myocyte 
contraction and Ca2+ transients had been observed. 
 
In vivo hemodynamic measurements Mice were anesthetized with a 2% Isoflurane 
and the right common carotid artery was isolated and cannulated with 1.4 French 
micromanometer (Millar Instruments, Houston, TX). LV pressure, LV end-diastolic 
pressure (LVEDP) and heart rate (HR) were measured by this catheter advanced into 
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the LV cavity, and data was recorded and analyzed on a PowerLab System (AD 
Instruments Pty Ltd., Mountain View, CA). These parameters as well as maximal values 
of the instantaneous first derivative of LV pressure (+dP/dtmax, as a measure of cardiac 
contraction) and minimum values of the instantaneous first derivative of LV pressure (-
dP/dtmin, as a measure of cardiac relaxation) were recorded at baseline and after 
administration of the β-adrenergic receptor (βAR) agonist, isoproterenol (Iso, 2ug/Kg and 
2mg/Kg i.p. injection) 
 
Western Blotting    Cytoplasmic and membrane protein were isolated from ventricular 
tissue using PBS lysis buffer containing: 0.5% Triton X-100, 5 mM EDTA (pH7.4), 
phosphatase inhibitors (10 mM NaF and 0.1 mM NaVO4), proteinase inhibitors (10 μg/ml 
aprotinin, 10 μg/ml leupeptin, 1mM phenylmethylsulfonyl fluoride, 5 μg/ml pepstatin A, 8 
μg/ml calpain inhibitor I & II, and 200 μg/ml benzamidine). Cardiac actin was isolated 
from resulting pellet using PBS lysis buffer containing 2% sodium dodecyl sulfate, SDS 
(FisherBiotech), 1% IGEPAL CA-630 (Sigma), 0.5 % deoxycholate (Sigma), 5 mM EDTA 
(pH 7.4), and proteinase inhibitors. Protein abundance and phosphorylation levels in 
isolated protein were analyzed with Western blot analysis as described previously 8. 
Target antigens were probed with the following antibodies: phospholamban (PLB) 
(Upstate Biotechnology), RyR (Research Diagnostics), α-sarcomeric actin (Sigma), 
LTCC-α1C subunit (Chemicon), GAPDH (Serotec), PS2809-RyR, PS16-PLB, and PT17-
PLB (Badrilla). 
 
Statistics   Data are presented as mean±SEM. Between-group comparisons were 
performed by using the one way ANOVA or t-test. For all tests, statistical significance 
was set at P<0.05. 
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Onlinel Figure I A. Representative images of cardiac tissue sections stained with TTC 
after 4 weeks MI. B. Representative images of fixed hearts and  middle cross sections with 
infarct zone.  C. Representative cardiac histology tissue sections with H&E staining after 4 
weeks MI.
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Online Figure II Representative Western blots of Ca2+ regulatory proteins in 
heart tissues from WT and S2808A mice 4 weeks after sham or MI-operated 
procedure.
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Online Figure III   A. Voltage dependence of ICa,L activation in sham WT (n=6) 
and S2808A myocytes (n=5) +/- Iso (1umol/L). B. Voltage dependence of ICa,L
activation in post-MI WT (n=6) and S2808A myocytes (n=5)  +/- Iso (1umol/L). 
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Online Figure IV  A-B. Representative traces of sham and post-MI myocyte contractions  
-/+ Iso (100nmol/L) at 0.5 Hz pacing rate from WT and S2808A hearts. C-D.
Representative traces of sham and post-MI myocyte contractions -/+ Iso (100nmol/L) at 2 
Hz pacing rate from WT and S2808A hearts. 
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Online Figure V  A-B. Representative traces of sham and post-MI myocyte Ca2+
transients -/+ Iso (100nmol/L) at 0.5 Hz pacing rate from WT and S2808A hearts. C-D.
Representative traces of sham and post-MI myocyte Ca2+ transients -/+ Iso (100nmol/L) 
at 2 Hz pacing rate from WT and S2808A hearts. 
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Online Figure VI A. Cardiac function (dP/dT ) with Isoproterenol treatment (2ug/Kg and 
2mg/Kg i.p.injection) was determined by hemodynamics measurement using Miller 
catheterization. B. Peak dP/dT after Iso treatment was assessed in WT and S2808A mice.
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